2023 ACMT | Annual Scientific Meeting

2023 ACMT | Annual Scientific Meeting

Includes a Live In-Person Event on 03/31/2023 at 8:00 AM (PDT)

  • Register
    • Early bird pricing available!
    • Non-member - Tier I - $795
    • Non-member - Tier II - $500
    • Non-member - Tier III - $400
    • Non-member - Tier IV - $350
    • Member - Tier I - $650
    • Member - Tier II - $425
    • Member - Tier III - $350
    • Member - Tier IV - $300
    • Regular Price after 02/17/2023 12:59 AM
    • Non-member - Tier I - $995
    • Non-member - Tier II - $600
    • Non-member - Tier III - $500
    • Non-member - Tier IV - $450
    • Member - Tier I - $750
    • Member - Tier II - $525
    • Member - Tier III - $450
    • Member - Tier IV - $400

2023 ACMT Annual Scientific Meeting

Early bird registration ends at midnight, Thursday, February 16th!

March 31 - April 2, 2023
San Diego, Marriott La Jolla, San Diego, CA

Download Event Brochure

The ACMT Annual Scientific Meeting (ASM) is an opportunity for specialists in the field to gather together to learn from the cutting-edge research of their peers. After a 2-year hiatus, ACMT is back for a fully in-person meeting in 2023, complete with all the networking and social opportunities that make our events so rich with engagement. The day preceding the annual meeting, ACMT will have it’s Pre-Symposium on “Self-Harm, Suicidality, and the Poisoned Patient: The Intersection of Toxicology and Mental Health” on March 30th. And the day before that, on March 29th, we are delighted to announce that our sister organization, the American Academy of Clinical Toxicology (AACT) will be joining us with their own half-day Pre-Symposium “DEI in Toxicology: What it Means for Patients and Learners.”


Continuing Education

This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 14.25 Interprofessional Continuing Education (IPCE) credit for learning and change. 

Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

Purchase CE Credits


Questions?

Please write to ACMT at events@acmt.net.

Registration Rates

Learn about Registration Rate Tiers

image

Early-Bird Rate*

Early-bird rates expire at midnight on FEBRUARY 16, 2023. Fees increase to the Regular Rate after this date, no exceptions.

Cancellation Policy

Cancellation Policy: Cancellations received in writing on or prior to February 16, 2023 will be refunded subject to a $150 processing fee. No refunds will be given after February 16, 2023. Please send cancellation request to ACMT at events@acmt.net.

Agenda

This agenda is subject to change. All times listed are in local, Pacific Time Zone.


Friday, March 31, 2023


7:45 - 8:00 AM - Welcome & Introductions


8:00 - 9:00 AM

Platform Session 1

001. Postpartum Maternal Opioid Therapy and The Risk of Adverse Neonatal Outcomes
David Juurlink, MD, FACMT, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

002. Exposure to the Endocrine-Disrupting Metal Lead and Serum Estrogen Levels in Women
Anna Gerald, Medical Student, Mercer University School of Medicine, Macon, GA

003. Pediatric Risk of Mortality-III (PRISM III) and Pediatric Index of Mortality (PIM3) Scores among Pediatric Poisonings
Rachel Culbreth, PhD, MPH, American College of Medical Toxicology, Phoenix, AZ

004. Can We Predict the Next “Benadryl Challenge?” A Side-by-Side Comparison of RADARS® Web Monitoring and NPDS Data
Hannah St. Francis, MD, New York University School of Medicine, New York, NY


9:00 - 9:45 AM

Donovan Lectureship: Gut-Brain Axis and Psychoneuroendocrinology: Translation to Addiction Medicine

Lorenzo Leggio, MD, PhD, Branch Chief, NIDA and NIAAA, Acting Clinical Director and Deputy Scientific Director, NIDA, National Institutes of Health, Baltimore, MD


9:45 - 10:30 AM

The PFAS Epidemic: Addressing The Challenge

Alan Woolf, MD, MPH, FAAP, FACMT, FAACT, Associate Chief Medical Education Officer, Boston Children's Hospital, Boston, MA


10:30 - 11:30 AM - Poster Session 1
10:40 - 11:20 AM - Moderated Poster Forum 1


11:30 - 1:00 PM - Break / Committee Meetings


1:00 - 2:00 PM

X-Factor: Xylazine

Joshua DeBord, PhD, Senior Scientist, The Center for Forensic Science Research and Education, Willow Grove, PA
Michael Levine, MD, FACMT, Associate Professor, Director of Toxicology, Department of Emergency Medicine, University of California, Los Angeles, CA
Matthew S. Salzman, MD, Assistant Professor of Emergency Medicine, Cooper Medical School of Rowan University, Camden, NJ


2:00 - 3:00 PM

ASAM Panel | Tricks of the Trade: Pain and Perioperative Management in Patients with Opioid Use Disorder

Katherine Katzung, MD, FASAM, Chair, Emergency Department; Director, Toxicology & Addiction Medicine Program, Abbott Northwestern Hospital, Minneapolis, MN
JoAn Laes, MD, FACMT, FASAM, Addiction Medicine Physician, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN
Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY

Developed in Collaboration with the American Society of Addiction Medicine (ASAM).


3:00 - 3:30 PM

Annual Review of Medical Toxicology Publications - Articles You May Have Missed from 2022-2023

Daniel J. McCabe, MD, Director of the Division of Medical Toxicology & Associate Medical Director, University of Iowa & Iowa Poison Control Center, Iowa City, IA


3:30 - 5:00 PM - Break / Committee Meetings


5:00 - 6:30 PM - ACMT Annual Members Meeting and Awards Ceremony


6:30 - 8:00 PM - 30th Anniversary - President's Reception


Saturday, April 1, 2023


7:45 - 8:00 AM - Morning Announcements

Becker Medal Presentation


8:00 - 9:00 AM

Platform Session 2

072. Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Utilization in Acute Poisonings: A Retrospective Study of Extracorporeal Life Support Organization’s ECMO Registry
Andrew Piner, MD, Department of Emergency Medicine, University of Maryland Medical Center, Baltimore, MD

074. Number and Variety of Detected Substances in a Regional Sample of the Illicit Drug Supply
Frank Dicker, MD, Washington University in St. Louis School of Medicine, St. Louis, MO

075. Trends in Medical Outcomes: A Retrospective Review of the National Poison Data System 2007-2021
Rita Farah, MD, Division of Medical Toxicology, Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville, VA

141. The California Substance Use Line: A Collaboration Between the California Poison Control System and National Clinician Consultation Center
Craig Smollin, MD, FACMT, University of California San Francisco, San Francisco, CA


9:00 - 9:30 AM

MedTox and Modern Warfare: Radiation and Current Events

Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT, Professor of Department of Emergency Medicine Professor, Emory University, Atlanta, GA


9:30 - 10:15 AM

ACMT Career Achievement Award | B is for Botulism

B. Zane Horowitz, MD, FACMT, Associate Medical Director of Oregon-Alaska-Guam Poison Centers; Medical Director of Utah Poison Control Center; Professor of Emergency Medicine, Oregon Health and Science University, Portland, OR


10:15 - 11:15 AM - Poster Session 2
10:25 - 11:05 AM - Moderated Poster Forum 2


11:15 - 12:15 PM

AACT Panel

Meghan Spyres, MD, FACMT, Clinical Associate Professor of Emergency Medicine, Banner – University Medical Center Phoenix, Phoenix, AZ
Joshua D. Trebach, MD, Emergency Medical Physican and Medical Toxicologist, University of Iowa Hospitals and Clinics, Iowa City, IA

Developed in Collaboration with the American Academy of Clinical Toxicology (AACT).


12:15 - 2:15 PM - Break / Committee Meetings


2:15 - 3:45 PM

MedTox Case Panel: Case-Based Conundrums

Complications of Naloxone Administration and Inappropriate Early Code Status Change in a Case of Opioid Overdose
Ryan Cole, MD, Fellow, University of Virginia, Charlottesville, VA

Saw Scale Viper (Echis carinatus sochureki) Envenomation Successfully Treated with Inoserp© MENA, and Experience with the AZA Antivenom Index
Arthur Daigh, MD, Fellow, Indiana University/Indiana Poison Center, Bloomington, IN

Recurrent and Escalating Salicylate Poisoning
Betty Shuk Chan, MBBS, Attending, Prince of Wales Hospital, Sydney, AU


3:45 - 5:15 PM

MedTox Shark Tank Research Forum

Gastrointestinal Sequestration of Lipid Soluble Toxins
Noah Berland, MD, Fellow - 2nd Year, Rutgers New Jersey Medical School Medical Toxicology Fellowship, Newark, NJ

Does Knowledge Inspire Action?
Juliana Chang, MD, Fellow - 2nd Year, Northwell Health Medical Toxicology, Manhasset, NY

Identification of Barriers to Placement in IPV Shelters for Individuals with Substance Use Disorders
Tori Erhardt, MD, Medical Resident, Emory University School of Medicine, Atlanta, GA

Climate Trends In US Incidence of Algal Toxin and Algal Toxin Associated Exposures
Brett Johnson, MD, Fellow - 1st Year, UMass Memorial Toxicology Fellowship, Worcester, MA

Pharmacogenomic Investigation of Cannabis Hyperemesis Syndrome and Cannabis Use Disorder
Jennifer Zacharia, MD, Fellow - 1st Year, UMass Memorial Toxicology Fellowship, Worcester, MA


5:15 - 6:45 PM

Open Mic Competition

Which to Lick? Take Your Pick
Alexia Armenta, MD,  Fellow - 1st Year, Toxikon Consortium, Chicago, IL

How Sweet It Is (to be cared by you)
Juliana Chang, MD, Fellow - 2nd Year, Northwell Health Medical Toxicology, Manhasset, NY

From Fang to Needle: Venom Throughout History
Samy Chettat, MD, Fellow - 1st Year, Oregon Health and Sciences University, Aloha, OR

The Sensitive Artist
Matthew Dernbach, MD, Medical Resident, Medical University of South Carolina, Charleston, SC

Aum Shinrikyo – the cult of toxicologic terrorism
Michael Kennan, MD, Fellow - 2nd Year, SUNY Upstate Medical University, Syracuse, NY

Bring Back the Barb
Christopher Mitchell, MD, Fellow - 1st Year, Einstein Healthcare Network, Philadelphia, PA

Pruno: A Recipe for Paralysis
Tuyet-Anh Nguyen, MD, Fellow - 2nd Year, Rutgers University, Newark, NJ

Reframing Toxicology: A “Disease” of Socioeconomic Disparities
Josue Zozaya, MD, Medical Resident, UTSW Emergency Medicine


Sunday, April 2, 2023


7:50 - 8:00 AM - Morning Announcements


8:00 - 9:00 AM

Lightning Oral Session

136. Poison Center Utilization by Law Enforcement and Correctional Facilities: Single Center Data 2003-2022
David Schaffer, MD, University of Virginia, Charlottesville, VA

137. Yearly Trends and Regional Patterns of Novel Psychoactive Substances in Opioid Overdose Patients
Paul Wax, MD, FACMT, American College of Medical Toxicology, Phoenix, AZ

138. Young Adults With Acute Opioid Overdose: What Substances Are Actually Involved?
Madeline Renny, MD, Icahn School of Medicine at Mount Sinai, New York, NY

139. Intravenous Buprenorphine Conversion for Hospitalized Patients on Opioid Agonists
Brandtly Yakey, DO, Michigan Poison and Drug Information Center at Wayne State University School of Medicine, Detroit, MI

140. A Sunny Disposition: Substance Use Navigator (SUN) Associated with Decreased Hospital Utilization
Daniel Lasoff, MD, UC San Diego, Department of Emergency Medicine, Division of Medical Toxicology, San Diego, CA

142. Systemic Toxicity after Rattlesnake Envenomation in Patients Using Angiotensin Converting Enzyme Inhibitors in the North American Snakebite Registry
Anne-Michelle Ruha, MD, FACMT, Banner - University Medical Center, Phoenix, AZ


9:00 - 10:00 AM

International Panel

APAMT: Insight to Aluminum Phosphide Poisoning and its Treatment
Nasim Zamani, MD, Fellowship of Clinical Toxicology, Shahid Beheshti University, Aliso Viejo, CA

EAPCCT: Tetrodotoxin Poisoning and Lessepsian Migration to The Mediterranean Sea
Ophir Lavon, MD, Head, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel

MENATOX: Environmental and Occupational Challenges in Lebanon with the Current Situation
Tharwat El Zahran, MD, Assistant Professor of Emergency Medicine, Co-director of Toxicology Service, American University of Beirut Medical Center, Beirut, Lebanon

Developed in Collaboration with the Asia Pacific Association of Medical Toxicology (APAMT), European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), and the Middle East & North Africa Clinical Toxicology Association (MENATOX).


10:00 - 11:00 AM - Poster Session 3
10:10 - 10:50 AM - Moderated Poster Forum 3


11:00 - 11:25 AM - (pick 1 of 2)

Professional Development Workshops 1 & 2

Workshop 1: A Toxicologist Loose in the Med School, Opportunities for Undergraduate Medical Education
Brenna Michelle Farmer, MD, MBA, MS, Vice Chief of Clinical Services, Department of Emergency Medicine, NYP Brooklyn Methodist Hospital, New York City, NY
Jeffrey Suchard, MD,Professor of Clinical Emergency Medicine; Associate Dean for Basic Science Education, University of California, Irvine, Irvine, CA
Matthew Zuckerman, MD, Associate Professor, University of Colorado School of Medicine, Aurora, CO

Workshop 2: The 7 Words You Can't (shouldn't) Say in Toxicology Publications
Howard Greller, MD, FACMT, Associate Professor of Emergency Medicine, Rutgers University New Jersey Medical School, Newark, NJ
Mark B. Mycyk, MD, FACMT, FACEP, Chair of Research, Cook County Health, Chicago, IL
Kevin C. Osterhoudt, MD, MS, FACMT, Director, Section of Clinical Toxicology, Children’s Hospital of Philadelphia


11:35 - 12:00 PM - (pick 1 of 2)

Professional Development Workshops 3 & 4

Workshop 3: Can you Escape the Toxin? Developing your own Toxicology Escape Room for Adult Leaners
Alexis Cates, Attending Physician, Emergency Medicine and Medical Toxicology, Ochsner Medical Center, New Orleans, LA

Workshop 4: Supplementing Toxicology Fellowship Training to Enhance the Practice of Addiction Medicine
Leslie R. Dye, MD, FACMT, FASAM, FACCT, Clinical Professor, Emergency Medicine, Assistant Medical Director, Wright State University/Boonshoft School of Medicine, OneFifteen, Dayton, OH


12:00 - 12:30 PM 

A Brief History of Pharmaceutical Compounding and the Errors Associated with It

Christopher James Watson, MD, Emergency Medicine Attending Physician, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Boston, MA
James D. Whitledge, MD, Medical Toxicology Fellow, Boston Children's Hospital, Boston, MA


12:30 - 1:00 PM

Novel Treatments in the Pipeline for Envenomations

Nicklaus Brandehoff, MD, Assistant Clinical Professor, Toxicology Associates, Aurora, CO


1:00 - 1:30 PM

Making Social Media Nontoxic to Toxicologists

Joshua D. Trebach, MD, Emergency Medical Physican and Medical Toxicologist, University of Iowa Hospitals and Clinics, Iowa City, IA
Ryan Marino, MD, Assistant Professor, University Hospitals Cleveland & Case Western Reserve University School of Medicine, Cleveland, OH


1:30 - 2:00 PM

What You Need to Know About MyToxCert and Recertifying in Medical Toxicology

Robert G. Hendrickson, MD, FACMT, FACEP, FAACT, Director, Emergency Medicine Toxicology Fellowship; Associate Medical Director, Oregon Poison Center; Professor of Emergency Medicine, School of Medicine, Oregon Health & Science University, Portland, OR
Andrew Ian Stolbach, MD, MPH, FACMT, Associate Professor of Emergency Medicine, Johns Hopkins Medicine, Baltimore, MD

Has your abstract been selected for presentation as a Platform, Lightning Oral, Moderated Poster, or Poster? Congratulations! Please refer to the following guidelines when creating your presentation:

Platform Presentation Guidelines

Lightning Oral Presentation Guidelines

Moderated Poster Presentation Guidelines

Poster Presentation Guidelines


Questions? Write to asmresearch@acmt.net

Katherine Boyle, MD

Director of Global Patient Safety & Risk Management

Alnylam Pharmaceuticals

Katherine Boyle, MD is an emergency medicine physician and medical toxicologist who recently took a position at Alnylam Pharmaceuticals as Director of Global Patient Safety & Risk Management. She was previously an attending at Beth Israel Deaconess Medical Center (BIDMC) and an Assistant Professor of Emergency Medicine at Harvard Medical School. At BIDMC, she was the Director of the Division of Medical Toxicology and Associate Director of Research for the Emergency Department. In addition, she was a faculty member for the Boston Children's Hospital medical toxicology fellowship and the MA/RI Poison Control Center.  She is a graduate of the University of Massachusetts Medical School where she stayed to complete her emergency medicine residency and medical toxicology fellowship.

Nicklaus Brandehoff, MD

Assistant Clinical Professor

Toxicology Associates

Dr. Brandehoff is board certified in emergency medicine, medical toxicology, and addiction medicine with a focus on envenomation research. He has an appointment as Assistant Clinical Professor of Emergency Medicine at the University of Colorado School of Medicine and is faculty at the Rocky Mountain Poison and Drug Center. He is also the President and Medical Director for the Asclepius Snakebite Foundation, a 501(c)3 non-profit, that focuses on improving snakebite education and management in West Africa.

Alexis Cates, DO

Attending Physician, Emergency Medicine and Medical Toxicology

Ochsner Medical Center

Alexis Cates, DO trained in Emergency Medicine and Medical Toxicology at Einstein Medical Center in Philadelphia, PA.  She recently returned home to New Orleans, LA and is now working to develop a Medical Toxicology division at Ochsner Medical Center.  Professionally, she enjoys academics, perinatal toxicology, and health policy.  She is the mother of two active boys, and she and her husband enjoy road trips and adventures with the kids.

Peter Chai, MD, MMS

Assistant Professor

Brigham and Women's Hospital

Dr. Peter R Chai is an assistant professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research primarily involves the development and implementation of technological solutions that detect and respond to changes in disease. These translational projects ranges from design of novel robotic and sensor systems in animal models to human clinical trials to test the implementation of injectable and ingestible sensor systems and overlying behavioral science architecture to respond to disease states.  Specifically, Dr. Chai is interested in applying ingestible electronic sensor systems to understand medication adherence in the context of substance use and HIV treatment/prevention. His work in developing ingestible sensors and their overlying behavioral interventions as closed loop systems to measure, reinforce and provide tools for PrEP and ART adherence has been funded by the National Institutes of Health and industry partners.

Joshua DeBord, PhD

Senior Scientist

The Center for Forensic Science Research and Education

Dr. Joshua (Josh) DeBord is a Senior Scientist at the CFSRE working in the areas of forensic toxicology and forensic chemistry. Dr. DeBord joined the CFSRE in early 2022 and performs R&D on challenging toxicological casework and profiles physical drug evidence on projects related to the CFSRE’s drug characterization initiatives, including CFSRE’s NPS Discovery program.

Dr. DeBord graduated with a B.S., M.S., and Ph.D., each in Chemistry, from Florida International University (FIU) in Miami, FL. Dr. DeBord’s doctoral research was conducted under the mentorship of Professor José Almirall on profiling and geographic provenance determination of heroin. Before joining CFSRE, Dr. DeBord was employed at the North Louisiana Crime Lab in Shreveport, LA, as a forensic chemist and toxicologist. Beginning there in 2018, Dr. DeBord and two colleagues started the toxicology section from only blood ethanol analysis to ISO/IEC 17025:2017 accreditation for qualitative determination and quantitative measurement of most drugs by March 2020. He also assisted with the development and implementation of the North Louisiana Crime Lab’s statistical sampling procedure to reduce backlog in the large-seizure drug casework. He continued to perform casework analysis and expert testimony before joining CFSRE in 2022.

Dr. DeBord is passionate about teaching, research, and mentorship. His research interests focus on applied research for increasing the capabilities of publicly funded forensic labs and improving the work experience for forensic professionals.

Leslie R. Dye, MD, FACMT, FASAM, FACCT

Clinical Professor, Emergency Medicine, Assistant Medical Director

Wright State University/Boonshoft School of Medicine, OneFifteen

Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

Tharwat El Zahran, MD

Medical Director, Assistant Professor of Emergency Medicine

American University of Beirut Medical Center

Dr. Tharwat El Zahran is an Assistant Professor of Emergency Medicine and the Medical director for the emergency department at the American University of Beirut Medical Center (AUBMC)

She completed a fellowship training in medical toxicology at Emory University and CDC, and currently co-directs the medical toxicology service at AUBMC.

Brenna Farmer, MD, MBA, MS

Vice Chair & Chief of Emergency Medicine

NYP Brooklyn Methodist Hospital & Weill Cornell Medicine Department of Emergency Medicine

Dr. Brenna Farmer is Chief of Emergency Medicine at NY Presbyterian Brooklyn Methodist Hospital and Vice Chair in the Department of Emergency Medicine at Weill Cornell Medicine's Department of Emergency Medicine. She trained in Emergency Medicine at Vanderbilt University Medical Center and in toxicology at NYU/Bellevue and the New York City Poison Control Center. She earned her medical degree from East Carolina University's Brody School of Medicine and her executive MBA from Cornell and MS in Healthcare Leadership from Cornell's Weill Cornell Graduate School of Medical Sciences. Her major academic interests are medication safety, patient safety, and acute bedside care of the toxicologic patient.

Howard Greller, MD, FACMT

Associate Professor of Emergency Medicine

Rutgers University New Jersey Medical School

Rob Hendrickson, MD

Professor of Emergency Medicine, Medical Director, Program Director

Oregon Health and Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology

Dr. Hendrickson is a Professor of Emergency Medicine and Medical Toxicologist at the Oregon Health and Science University (OHSU) in Portland, Oregon. He is the Program Director of the Fellowship in Medical Toxicology at OHSU and the Medical Director of the Oregon Poison Center, serving Oregon, Alaska, and Guam.

B. Zane Horowitz, MD, FACMT

Associate Medical Director

Oregon-Alaska-Guam Poison Centers

Dr. B. Zane Horowitz served as the medical director of the Oregon-Alaska-Guam Poison Center for 22 years. He also served as the medical director for the Utah Poison Control Center for 7 of those years. He currently continues to teach at Oregon Health and Science University in medical toxicology, and has authored over 90 publications.

Katherine Katzung, MD, FACEP, FASAM

Director of Addiction & Toxicology Program & Emergency Care Physician

Abbott Northwestern Hospital & Emergency Care Consultants

Katherine Katzung, MD is an attending physician in the emergency department at Abbott Northwestern, where she serves as chair of the department.  Additionally, she is the medical director of the hospital’s addiction medicine and toxicology program, which began in 2020 after she received grant funding to initiate a hospital-based toxicology/addiction medicine consult service as well as an  emergency department-based addiction medicine "bridge" clinic to provide continuity of care for patients initiated on Suboxone.  This innovative program allows patients evaluated at Abbott Northwestern in the emergency department or inpatient units continuity of care, while focusing on harm-reduction strategies, until they can be given a warm hand-off to community providers.

A graduate of the University of Minnesota School of Medicine, she completed emergency medicine training at Regions Hospital in St. Paul and additional fellowship training in medical toxicology.  She is board certified in emergency medicine, medical toxicology, and addiction medicine.  Her clinical interests surround the intersection of these 3 specialties, with special focus on early ED & hospital-based interventions to evaluate and treat substance use disorder, including initiation of medication assisted therapies.

She volunteers as a consultant for the Minnesota Poison Control System in addition to serving on the board of the Steve Rummler HOPE Network and acts as medical director of its overdose prevention program.

Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT

Professor, Department of Emergency Medicine

Emory University School of Medicine

Born in 1975 and raised in Beirut, Lebanon, Dr. Kazzi trained in Emergency Medicine at Emory University in Atlanta (2000-03) where he served as a chief resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) between 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an associate professor at the department of Emergency Medicine at Emory University in Atlanta, Georgia as well as the director of the International Toxicology Postdoctoral Fellowship Program at Emory University (http://www.em.emory.edu/services/toxicology/international_postdoc_training.html).

He is also the assistant medical director of the Georgia Poison Center (www.georgiapoisoncenter.org) and a medical toxicologist at the Radiation Studies Branch of the National Center for Environmental Health at the CDC (https://www.cdc.gov/nceh/radiation/) where he participates in emergency preparedness and response activities in radiation.

As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of Radiation and International Toxicology. Over the past decade, he developed strong ties to India in the areas of medical toxicology, mass gathering medical preparedness, radiation emergency medicine, blast injuries and hazmat. Through his collaboration with the CDC, AIIMS, and PGIMER Chandigarh, he has delivered and co-directed the first Advanced Hazmat Life Support trainings in Ahmedabad and Delhi. He organized a number of training conferences in Nashik, Pune, Ujjain and Delhi and has been an invited speaker at the annual INDUS EM world congress. He is an active and founding board member of the Middle East North Africa Toxicology Association (www.menatox.org) and currently serves as its President. He is also a board member and chairs the International Committee of the American College of Medical Toxicology (www.acmt.net).

JoAn Laes, MD, DFASAM, FACMT

Addiction Staff Physician

Abbott Northwestern Hospital, Allina Health

JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

Ophir Lavon, MD

Head of Clinical Pharmacology and Toxicology Unit

Clinical Pharmacology and Toxicology Unit, Carmel Medical Center

Ophir Nelson is a Doctor of Medicine (MD)at the Rappaport Faculty of Medicine, Technion–Israel Institute of Technology. He is also a Board-Certified Expert in Internal Medicine, Clinical Pharmacology and Toxicology Chair, a Israel Society of Toxicology. Dr. Ophir serves on the Israel Medical Association as a Board member, and is a member of the European Association of Poisons Centres and Clinical Toxicologists. He is head of the Clinical Pharmacology and Toxicology Unit, Carmel Medical Center in Haifa, Israel. Dr. Ophir is a Clinical Senior Lecturer at the Rappaport Faculty of Medicine. He also serves as the Technion–Israel Institute of Technology Chair in the National Antidote Stockpiling Committee. Dr. Ophir additionally serves in the Israel Ministry of Health as a Board member, and is a member of the Israel Association for Clinical Pharmacology, Israel Medical Association Member, and the American College of Medical Toxicology. He is the Former Head, Patient Safety and Risk Management Unit, Carmel Medical Center in Haifa, Israel.

Lorenzo Leggio, MD, PhD

Branch Chief & Acting Clinical Director

NIDA & NIAAA

Dr. Lorenzo Leggio is a Senior Investigator in the NIH Intramural Research Program (IRP) with faculty appointments both at NIDA and NIAAA. He serves as Chief of the Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, a joint NIDA and NIAAA laboratory. He also serves as the NIDA Deputy Scientific Director, NIDA Acting Clinical Director, and Chief of the NIDA IRP Translational Addiction Medicine Branch. He also serves as a NIH Senior Attending Medical Staff and as senior medical advisor to the NIAAA Director. Dr. Leggio received his M.D. and Ph.D. from the Catholic University of Rome and ‘Agostino Gemelli’ hospital, where he also completed residency and received Board Certification in Internal Medicine. He was a visiting research associate, then postdoctoral research associate in Psychiatry and Human Behavior at Brown University, Providence, RI. In 2010, he joined the faculty of the Brown University Medical School as Assistant Professor at the Brown University Center for Alcohol and Addiction Studies, where he still holds an adjunct appointment as Professor in Behavioral and Social Sciences. He is also an Adjunct Professor of Addiction Medicine at Johns Hopkins University and Adjunct Professor of Neuroscience at Georgetown University. 

Dr. Leggio’s clinical research has been primarily focused on the treatment of alcohol and substance use disorders, with a special emphasis on the role of microbiome-gut-liver-brain and neuroendocrine pathways as well as GABAergic pathways; and on the medical consequences of alcohol use disorder, focusing on alcohol-associated liver disease. As a Principal Investigator at Brown University, Dr. Leggio received extramural research funding from NIAAA and NIDA, as well as from Brown University, the European Foundation for Alcohol Research, ABMRF/The Foundation for Alcohol Research, and the Brain and Behavior Research Foundation (NARSAD Young Investigator Award). At Brown University first, and at the NIH since 2012, Dr. Leggio, together with his team, colleagues and collaborators have pioneered and conducted work on medication development, on the role of the microbiome-gut-liver-brain axis and on the role of neuroendocrine pathways in addictive behaviors via human laboratory studies and clinical trials as well as via translational and reverse translational experimental medicine approaches. 

In 2022, Dr. Leggio was elected Fellow of the American College on Neuropsychopharmacology. Among other awards, Dr. Leggio received the 2008 Nordmann Award from the European Society for Biomedical Research on Alcoholism, the 2016 Early Career Investigator Award from the Research Society on Alcoholism, the 2018 Eva King Killam Award from the American College on Neuropsychopharmacology and the 2020 Jacob P. Waletzky Award from the Society for Neuroscience.

Michael Levine, MD, FACMT

Associate Professor of Emergency Medicine

University of California, Los Angeles

Michael Levine is a Los Angeles native, who completed his emergency medicine residency at the Harvard Affiliated Emergency Medicine program, based out of Brigham and Women’s Hospital and Massachusetts General Hospital. After residency, he completed his medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ. After staying as faculty for a year in Phoenix, he moved back to Los Angeles, where he joined the faculty at USC. He is currently the division chief of medical toxicology. He is actively involved in patient care, research, and serves on numerous hospital and university committees. He is an active member of American College of Emergency Physicians, the American College of Medical Toxicology, and is a member of the Toxicology Investigator's Consortium.

Dan McCabe, MD

Director of the Division of Medical Toxicology & Associate Medical Director

University of Iowa & Iowa Poison Control Center

Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Assistant Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Associate Medical Director for the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.

Elizabeth Moore, DO

Assistant Professor of Clinical Emergency Medicine

Weill Cornell Medicine

Dr. Moore is currently an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at Weill Cornell Medicine in New York City.  She completed her Emergency Medicine Residency training at Lehigh Valley Health Network in and her Fellowship in Medical Toxicology at Banner-University Medical Center in Phoenix. She is actively involved in Women in Toxicology (WiT), and helps to produce the  “Tox in Ten” and “ ACMT Highlights” Podcast.

Mark Mycyk, MD

Chair of Research

Cook County Health

Mark Mycyk currently serves as Editor-in-Chief of Journal of Medical Toxicology and Chair of Research in the Department of Emergency Medicine at Cook County Health in Chicago.

Todd Phillips, MD

Director of Toxicology

Integrative Emergency Services

Dr. Phillips is a graduate of Texas A&M University, Class of 2007, with a Bachelor’s in Biomedical Science.  He completed medical school at Texas Tech University School of Medicine in 2011 and attended the University of Pittsburgh for both residency in Emergency Medicine and fellowship in Medical Toxicology from 2011 – 2016.  Following graduation, he accepted a position at John Peter Smith in Fort Worth, Texas where he served as their Assistant Program Director for the Emergency Medicine residency program and founded the inaugural Division of Medical Toxicology.  Dr. Phillips then transitioned to University of Texas Southwestern in Dallas, Texas where he served as the Program Director of the Medical Toxicology Fellowship. Dr. Phillips is looking forward to his upcoming transition to Director of Toxicology for Integrative Emergency Services in Dallas/Fort Worth. His professional interests include medical education, medical toxicology advocacy, and alcohol withdrawal. 

Matthew Salzman, MD

Assistant Professor

Cooper Medical School of Rowan University

Matthew Salzman received his Bachelor of Arts in Music from the University of Rochester and his Medical Degree from the Sidney Kimmel Medical College at Thomas Jefferson University.  He trained in Emergency Medicine and Medical Toxicology at Drexel University College of Medicine.  Currently, he is an Assistant Professor of Emergency Medicine in the Division of Medical Toxicology and Addiction Medicine at Cooper Medical School of Rowan University.  He is the Medical Director for the In-patient Addiction Medicine Consult service as well as Medical Director for Research for Addiction Medicine at Cooper.  He is also a volunteer consultant in toxicology for the Children's Hospital of Philadelphia and the Philadelphia Poison Control Center.

Jeffrey Suchard, MD

Professor of Clinical Emergency Medicine & Associate Dean for Basic Science Education

University of California, Irvine

Jeffrey Suchard is an Emergency Physician and Medical Toxicologist at the University of California, Irvine.  After undergraduate studies in Biochemistry at UC Berkeley, he attended medical school at UCLA, EM residency at UConn, then completed medical toxicology fellowship in Phoenix, AZ.  Dr. Suchard has worked clinically at UC Irvine since 1999 and began his current involvement in medical student education in 2010.  He teaches Epidemiology & Biostatistics to the MS1 class (since 2010), is the course director for MS2 Medical Pharmacology (since 2011), and serves as Associate Dean for Basic Science Education (since 2014).

Trevonne Thompson, MD

Professor of Emergency Medicine & Medical Toxicology

University of Illinois College of Medicine/Toxikon Consortium

Dr. Trevonne M. Thompson is an attending emergency physician and medical toxicologist at UI Health and a tenured professor of Emergency Medicine and Medical Toxicology at the University of Illinois College of Medicine (UICOM). He obtained his undergraduate degree from Xavier University of Louisiana in New Orleans. After graduating with a degree in Biology and minors in Chemistry and Spanish, he attended medical school at the Feinberg School of Medicine at Northwestern University in Chicago. He served his emergency medicine residency at Cook County Hospital (now Stroger Hospital of Cook County). After serving as Chief Resident in Emergency Medicine, he completed a Medical Toxicology fellowship at the Toxikon Consortium in Chicago. Dr. Thompson is the head of the Division of Medical Toxicology within the Department of Emergency Medicine at UICOM. He leads the medical toxicology consultation service and clinic at UI Health. He is a consultant to the Illinois Poison Center and is an associate program director for the Toxikon Consortium Medical Toxicology Fellowship.

Dr. Thompson is the Associate Dean for Admissions for the University of Illinois College of Medicine. He is a past chair of the Emergency Medicine Section of the National Medical Association.

Michael Toce, MD, MS

Instructor of Pediatrics

Boston Children's Hospital/Harvard Medical School

Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center.

Joshua Trebach, MD

Emergency Medicine Physician & Medical Toxicologist

University of Iowa Hospitals and Clinics

Josh Trebach is an emergency medicine physician and medical toxicologist at the University of Iowa Hospital and Clinics. He completed his undergraduate training at Virginia Tech, medical school training and residency at Johns Hopkins, and toxicology fellowship at New York University/New York City Poison Control Center. Josh is currently the Director of Resident Medical Toxicology Education at the University of Iowa and is passionate about all things toxicology, medical education, social media, LGBTQ health, and animal rescue.

James Whitledge, MD

Medical Toxicology Fellow

Boston Children's Hospital

James Whitledge, MD is a Medical Toxicology Fellow at Boston Children's Hospital in Boston, MA. He is also an Emergency Physician at Beth Israel Deaconess Medical Center Boston, MA. In his free time he also is the current Co-Chair of the AACT Herbs & Dietary Supplements Section.

Alan D. Woolf, MD, MPH, FACMT, FAAP, FACCT

Associate Chief Medical Education Officer

Boston Children's Hospital

Dr. Alan D. Woolf is a pediatrician and medical toxicologist. He is the Associate Chief Medical Education Officer at Boston Children’s Hospital and a Professor of Pediatrics at Harvard Medical School. He is Medical Director of the Pediatric Environmental Health Center at Boston Children’s Hospital, Director of the Pediatric Environmental Health Fellowship Training Program, and Principal Investigator of the Region 1 New England Pediatric Environmental Health Specialty Unit. He is currently a member of the Executive Committee of the American Academy of Pediatrics’ Council on Environmental Health & Climate Change and a member of the PFAS Subcommittee of the National PEHSU Program. Dr. Woolf has served as a consultant regarding PFAS water contamination to both the New Hampshire and Massachusetts Departments of Public Health since 2014. He co-authored one of the first papers to describe the PFAS water contamination event in Portsmouth NH and was a ‘Community Liaison’ giving input to the NASEM Report on PFAS published in 2022. He is currently a member of the New Hampshire State Advisory Committee on PFAS and cancer. 

Dr. Woolf is a past-president of both the American Academy of Clinical Toxicology and the American Association of Poison Control Centers. In 2018, Dr. Woolf received the Career Achievement Award from the AACT and, in 2019, he was named the Louis Roche Lecturer by the European Association of Poisons Centers and Clinical Toxicologists. He is the Editor of the recent book The History of Modern Clinical Toxicology published by Elsevier Publishers in 2021.

Nasim Zamani, MD

Fellowship of Clinical Toxicology

Shahid Beheshti University

Nasim Zamani graduated from Azad University of Medical Sciences in Tehran, Iran in 2004. She started residency in Forensic Medicine and Clinical Toxicology in 2008 and finished the course with the first rank of the national board followed by fellowship program in clinical toxicology in Loghman Hakim Hospital- one of the largest in-patient clinical toxicology centers in the world- in affiliation with Shahid Beheshti University of Medical Sciences. After graduation, She started to work in the same setting as attending physician in 2014 where she was responsible for patient treatment, teaching, and research in the field. She has won three international grants in the field of clinical toxicology and is currently a board member of APAMT and a member of EAPCCT.

Matthew Zuckerman, MD

Associate Professor

University of Colorado School of Medicine

Dr. Matt Zuckerman is an medical toxicologist at the University of Colorado Anschutz Medical Campus and Rocky Mountain Poison & Drug Safety. He is the pharmacology content director for the CU School of Medicine curriculum.

Continuing Education

This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 14.25 Interprofessional Continuing Education (IPCE) credit for learning and change. 

Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

Purchase CE Credits

Key:

Complete
Failed
Available
Locked
Live In-Person Event
03/31/2023 at 8:00 AM (PDT)   |  2 days, 5 hours, 30 minutes  |  Attendance Required
03/31/2023 at 8:00 AM (PDT)   |  2 days, 5 hours, 30 minutes  |  Attendance Required